third quarter 2016
play

Third Quarter 2016 - PowerPoint PPT Presentation

!"#$%&'() !"#$%&'() *+#,-."/.&%('+&.0)1 *+#,-."/.&%('+&.0)1 2-%34!.'+%3')42+3542%460042+37 Third Quarter 2016 !"#$%&##'()*+,&'-.%/&0&%1&'-+22 Peter Culpepper, MBA, CPA Chief


  1. 8#("48#&()46"%.)4+34*()+3%))4.3:4F%$%0#,/%3' Q(O&,,+%+*(O%*O%"#O/+9#O-+00&.$O&.#O*3.O/*3.O/*)3$O&.#&$O*/O73$+(#$$O&(,O ,#9#0*-'#(%6O&(,OQO5&(%O%*O.#'+(,O&00O*/O<*3O&7*3%O%"#'O&$O%"#<O&,,O/3.%"#.O )*(%#8%O&(,O)*0*.O%*O*3.O&)%+*($:O!"#<O&.#U F: &O"+1"#.O-370+)O-.*/+0#O/*.OP.*9#)%3$6OPRIFHO&(,OPYIFHbO N: )*I,#9#0*-'#(%O,+$)3$$+*($O5+%"OV+1OP"&.'&O&7*3%O,.31O)*'7+(&%+*(O5*.4b L: *%"#.O$%.&%#1+)O&)%+9+%+#$O+()03,+(1O.#1+*(&0O0+)#($#$6O)*00&7*.&%+*($6OO +(9#$%'#(%$O&(,O$*O/*.%"bO&(,O Z: 1.&(%O-.*1.&'$O%"&%O)&(O"#0-O3$O/3.%"#.O/3(,O.#$#&.)": FH

  2. J%0.3#/.4?'(:+%) P"&$#OQQQO;%3,<UO fPRIFHO9$OC"#'*%"#.&-<O*.O`()*0<%+)OR+.&0O!"#.&-<O/*.O!.#&%'#(%O*/OS*)&00<O / G,9&()#,OC3%&(#*3$OT#0&(*'&6gOC0+(+)&0%.+&0$:1*9O^C!HNNdddec ^+(#OS+$%#,O ;+%#$6OdO+(O[;G6OFO+(OG3$%.&0+& / B+1"%O&)%+9#0<O .#).3+%+(16O FO-.#-&.+(1O%*O.#).3+% / P.*%*)*0OG'#(,#,O%*O#8-&(,O%"#O-*%#(%+&0O -&%+#(%O-**0 / Q(%#.+'O,&%&O#8-#)%#,O ,3.+(1O-#.+*,O*/O/3(,+(1O9+&O%"#OA+1"%$O`//#.+(1 / P"&$#OF7hNOC*'7+(&%+*(O;%3,<UOfPRIFHO+(OC*'7+(&%+*(O@+%"OP#'7.*0+]3'&7O/*.O / !.#&%'#(%O*/OT#%&$%&%+)OT#0&(*'&6gOOC0+(+)&0!.+&0$:1*9OQ,#(%+/+#.O^C!HN\\cLNF V#+(1O3$#,O+(O)*'7+(&%+*(O5+%"OT#.)42$OJ#<%.3,& / P*%#(%+&00<O/*.'+(1O-&.%O*/O&O)*)4%&+0O*/O,.31$O$+'+0&.O%*O%"&%O.#&0+]&%+*(O */O+'-*.%&()#O+(OYQRhGQK;O / %.#&%'#(% FF

  3. <+$%"54!.3&"%.'+&54E#0# <+$%"54!.3&"%.'+&54 E#0# H%&'.04?'(:+%) E#0#; / fGOP"&$#OFO;%3,<O*/OPRIFHOC"#'*&70&%+*(O*/O^#3.*#(,*).+(#O!3'*3.$OD^B!EOT#%&$%&%+)O%*O%"#O S+9#.6gOOC0+(+)&0!.+&0$:1*9OOQ,#(%+/+#.UO^C!HN_eLH_c: K&%&O/*.%")*'+(1O%*O7#O&((*3()#, / / ;#-&.&%#OP"&$#OFO;%3,<OII fGO;%3,<O%*OG$$#$$OPRIFHOC"#'*&70&%+*(O*/OC&()#.O*/O%"#OS+9#.6gOO C0+(+)&0!.+&0$:1*9OOQ,#(%+/+#.U ^C!HHed___F K&%&O/*.%")*'+(1O%*O7#O&((*3()#,O'*.#O(#&.I%#.' / / Q(%.&0#$+*(&0O+(=#)%+*(O5+%"OA*$#OV#(1&0O&(,O$<$%#'+)O)"#'*%"#.&-<O+(,3)#$O&(%+I%3'*.O +''3(+%<O+(O&O'3.+(#O'*,#0O*/O-&().#&%+)O)&()#.O P.#$$O.#0#&$#O %*,&<6O^*9#'7#.OFZ %" NHF_ / iPRIFHOQ(,3)#$OP*%#(%OQ''3(*1#(+)OG-*-%*$+$O+(OC*0*(OC&()#.OC#00$:g / `(1*+(1O5*.4O&(,O#8-#)%#,O ,&%&O/*.%")*'+(1O%*O7#O&((*3()#,O+(O(#&.I%#.' / FN

  4. H%&%3'4N4O,&#/+3>4C3$%)'#"4!"%)%3'.'+#3) !"+.,Oj3&.%#.6ONHF_O / ;#-%OFFIFLUOA*,'&(OWOA#($"&5OG((3&0OY#&0%")&.#OC*(/#.#()#6O^#5O?*.4OC+%< / ;#-%ONcINdUOV+*%#)"OQ(9#$%*.O>*.3'O/*.Oa0*7&0OP&.%(#.+(1O&(,OQ(9#$%'#(%6OV&$#06O / ;5+%]#.0&(, >*3.%"Oj3&.%#.6ONHF_OD-0&((#,E / K#)#'7#.O_%"Id%"OSKOT+).*OT&+(OB9#(%ONHF_OII S*$OG(1#0#$6OCGO / A*&,O;"*5O/*.OA+1"%$O`//#.+(1O%".*31"*3%OK#)#'7#.OII ^#5O?*.46O^?O / K#)#'7#.OOF_%"OI Fe%"OB;T`OG$+&ONHF_OC*(1.#$$OII ;3(%#) C+%<6O;+(1&-*.#O / K#)#'7#.OFL%"OI F_%"OQ(9#$%*.OT##%+(1$Ok P"+0+--+(#$6O;+(1&-*.#6O*%"#.O;BOG$+&(O0*)&%+*($ / FL

  5. !(P0+&4.3:4J%:+.4H%0.'+#3)46&'+$+'+%) A&,+*O(#5$O$#1'#(%O%*O.3(O*(OZHHO.&,+*O$%&%+*($O&).*$$O%"#O(&%+*(:O!"#O$#1'#(%O / +()03,#,Oj3*%#$O/.*'OB.+)O@&%)"#.O&(,OK.:O;&(=+9OG1&.5&0&:O l*<&OK&$$O*/O;'&00OC&-O^&%+*(O+(%#.9+#5O5+%"OP#%#.OC30-#--#.O%*O,+$)3$$O%"#O/3%3.#O*/O / P.*9#)%3$: C*(/#.#()#$O+()03,+(1UOB;T`6O!"#OG3$%.&0&$+&(OT#0&(*'&OC*(/#.#()#6O;+,*%+O / B'#.1+(1Oa.*5%"OC*(/#.#()#6OQ(%#.(&%+*(&0O;*)+#%<O/*.OT#0&(*'&OA#$#&.)"O C*(1.#$$6OV+*IB3.*-#6O&(,OQ(%#.(&%+*(&0O;*)+#%<O/*.OV+*0*1+)&0O!"#.&-<O*/OC&()#.: @#7+(&.O5+%"OT#0&(*'&OA#$#&.)"O>*3(,&%+*(O0#,O7<OK.:OR#.(O;*(,&4O*(O^*9#'7#.O / FZ6ONHF_: FZ

  6. H%0.'+#3)-+,)49+'-4H%>(0.'#")4.3:4*+>4!-."/. A#130&%*.$ / >KG / C"+(#$#O>KG / G3$%.&0+&(OA#130&%*.$ / `%"#.$ / V+1OP"&.'& / T#.)4 / P/+]#. / V*#".+(1#.O Q(1#0"#+' / `%"#.$ / F\

  7. Q":4R(."'%"4H%)(0')4.3:4*.0.3&%4?-%%'4M+>-0+>-') T*(%"0<O)&$"O73.(O/*)3$UOmF:\O'+00+*( / A#,3)+(1O)&$"O7<O/*)3$+(1OaWGO&)%+9+%+#$O&(,O73+0,+(1O*(O$%.#(1%"$O+(OAWK / @.&--+(1O3-O&00O*3%$%&(,+(1O0&5$3+%$O&1&+($%OP.*9#)%3$ / Q(+%+&%+(1O)*00#)%+*(O#//*.%$O&1&+($%O%"#O/*.'#.OCB` / C&$"O&(,O)&$"O#j3+9&0#(%$UO m\6Fcd6Hc_O / ;"&.#"*0,#.$2O#j3+%<UO m\6LHe6cFN / >*.O&,,+%+*(&0O+(/*.'&%+*(6O$##O*3.Oj3&.%#.0<O.#-*.%O*(O>*.'OFHIMO/+0#,O5+%"O%"#O;BCO / *(O^*9#'7#.OOe %" F_

  8. ?,%&+.04!"#SD4A#'%4N4?-."%-#0:%"4J%%'+3> C3..#(%0<O$)"#,30#,O/*.OT*(,&<6O^*9#'7#.ONd %" &%Oe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`)%*7#.ONF $% Fc

  9. TS+)'+3>4C3$%)'#"4H+>-')4U@@%"+3> Q(O)*((#)%+*(O5+%"O*3.O-.*-*$#,O.+1"%$O*//#.+(16O 5#O&.#O-0&((+(1O%*O.&+$#O3-O%*OmNFO'+00+*(O / /.*'O#8+$%+(1O$"&.#"*0,#.$O T*$%O*/O-.*)##,$O#8-#)%#,O%*O$3--*.%O1#(#.&%+(1O.&(,*'+]#,O,&%&O/.*'OPRIFHO+(O%.#&%+(1O0*)&0O / '#0&(*'&O+(O*3.O-"&$#OL6O%.#&%+(1O5+,#0<O'#%&$%&%+)O'#0&(*'&O+(O*3.OF7hNO)*'7*6O&(,O+(O %.#&%+(1O*(1*+(1O)&()#.$O*/O%"#O0+9#.O)0+(+)&0O5*.4 @#O"&9#O/+0#,O&OA#1+$%.&%+*(O;%&%#'#(%O*(O>*.'O;IFO5+%"O%"#O;BC6O73%O+%O+$O(*%O#//#)%+9#O / &(,O(*%O<#%O-.+)#,OD'3$%O*5(O$%*)4O%*O.#)#+9#,O.+1"%$O/*.O*//#.+(1E @#O#8-#)%O%*O4(*5O'*.#O$"*.%0<O&/%#.O*3.O^*9#'7#.ONd %" $-#)+&0O'##%+(1O*/O$%*)4"*0,#.$: / ;%*)4"*0,#.$O-&.%+)+-&%+(1O+(O%"#O.+1"%$O*//#.+(1O5+00O7#O#(%+%0#,O%*O-3.)"&$#O)*''*(O$%*)4O&(,O / 5&..&(%$O%*O-3.)"&$#O)*''*(O$%*)4: >*.O&,,+%+*(&0O+(/*.'&%+*(6O $##O*3.O.#1+$%.&%+*(O*/O$#)3.+%+#$O*(O>*.'O;IFhGO/+0#,O5+%"O%"#O / ;BCO*(O^*9#'7#.OF6ONHF_ Fd

  10. VW?T4E#//#34?'#&=4.3:42."".3')4G".:+3>4?(),%3)+#3 K3#O%*O%"#O0*5O%.&,+(1O-.+)#6O%"#O^?;BOTJ!O"&$O)*''#()#,O-.*)##,+(1$O%*O,#0+$%U / `3.O)*''*(O$%*)4O3(,#.O%"#O$<'7*0OPRC!6O&(, / `3.O)0&$$O*/O5&..&(%$O3(,#.O%"#O$<'7*0OPRC!@; / C*''*(O$%*)4O)3..#(%0<O%.&,#$O*9#.I%"#I)*3(%#.O3(,#.OPRC! / @#O&.#O&--#&0+(1O%"#O,#)+$+*(O*/O%"#O^?;BOA#130&%+*(O$%&// / >*.O&,,+%+*(&0O+(/*.'&%+*(6O$##O*3.O`)%*7#.OFZ %" -.#$$O.#0#&$#O !"#$%&'(%&()"*+,-./0( / 1%*23#"4#-,/.%-#50(6*44*&(7.*-8(#&$(9#""#&.0(7/02,&$,$(:;(<=7>(?@! Fe

  11. *()+3%))4?(//."D NH

  12. E0+3+&.04F%$%0#,/%3' Third Quarter 2016 !"#$%&##'()*+,&'-.%/&0&%1&'-+22 Eric Wachter, Ph.D. Chief Technology Officer !"#$%&$'()*+(,-). NF

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

  14. ?.@%4M."P#"4?'.'%/%3') / 34567'$#'+%'$%8&#,$9+,$.%+2'*0"9' 3(,#.1*+(1O)0+(+)&0O$%3,<O &$O&(O&70&%+9#O+''3(*%"#.&-<O/*.O$*0+,O%3'*.O)&()#.$O / 3:567'$#'+%'$%8&#,$9+,$.%+2'*0"9' 3(,#.1*+(1O)0+(+)&0O$%3,<O &$O&O%*-+)&0O%"#.&-<O/*.O+(/0&''&%*.<O,#.'&%*$#$ / ^#+%"#.OPRIFHO(*.OPYIFHO"&9#O.#)#+9#,O&--.*9&0O/*.O '&.4#%+(1O+(O&(<O)*3(%.<O NL

  15. U('0+3% / V.#&4%".*31"$O+(O`()*0*1<OO / Q(%.*,3)%+*(O%*OPRIFH / T#)"&(+$'O*/OPRIFH / C0+(+)&0OK#9#0*-'#(%O*/OPRIFH / ;3--0<OC"&+( / `9#.9+#5O*/OC0+(+)&0O!.+&0OP.*)#$$ / [-,&%#O*(OPYIFH / ;*'#OP#.$*(&0O`-+(+*($ / C*()03$+*($ NZ

  16. *"%.='-"#(>-)4+34U3&#0#>D / P.*1.#$$O+(O&(<O%#)"(*0*1<O*/%#(O/*00*5$O&O)*''*(O-&%" ;&%3.&%+*( S&3()" A&%+*(&0+%< [-%&4# K#9#0*-'#(% K+$)*9#.< N\

  17. *"%.='-"#(>-)4+34U3&#0#>D / P.*1.#$$O+(O&(<O%#)"(*0*1<O*/%#(O/*00*5$O&O)*''*(O-&%" :.)& ;%,<"#$+#= >00+,$.%+2';?"@&0+%1& ;?)&0$&%1& ;?)&0$&%1& A0"#,0+,$.% A0"#,0+,$.% B&+2$D+,$.% B&+2$D+,$.% B+,$.%+2'C##&##=&%,'+%*'(#& N_

  18. *"%.='-"#(>-)4+34U3&#0#>D / !"+$O-&%%#.(O+$O#9+,#(%O+(O'&(<O'#1&%.#(,$O+(O*()*0*1< / !"#.&-#3%+)OR&))+(#$ / !&.1#%#,O!"#.&-< / C"#)4-*+(%OQ("+7+%*.$ODQ''3(*I*()*0*1<6O*.OQI`E / B&)"O"&$O7##(O"&+0#,O&$O%"#O$*03%+*(O%*O'#0&(*'& / B&)"O"&$O7##(O&O'&=*.O$%#-O/*.5&., / B&)"O"&$O/&+0#,O%*Of$*09#gO'#0&(*'& Nc

  19. *"%.='-"#(>-)4+34U3&#0#>D / l&'#$OPOG00+$*( / Q(9#(%*.O*/O&(%+IC!SGIZO / >&%"#.O*/O'*,#.(O+''3(*I*()*0*1<O / S+4#0<O^*7#0O0&3.#&%#O+(O%"+$O,#)&,# / f@#2.#O+(O&(O#.&O5"#.#O5#O)&(O*))&$+*(&00<O,+$)3$$O)3.+(1O)&()#.:g / f@#O(##,O%*O/+(,O5&<$O%*O.*3%+(#0<O)3.#O)&()#.:g G-.+0ONHF_6OC#0030&.O Y*.+]*($UO!"+.,OQ(%#.(&%+*(&0OC*(/#.#()#O*(O%"#OP.*1.#$$O*/OA#1#(#.&%+9#O T#,+)+(#O&(,OQ%$OC30%3.&0OQ'-&)% Nd

  20. *"%.='-"#(>-)4+34U3&#0#>D Web Exclusives > f!"#.#O+$O#(*31"O-.*1.#$$O7#+(1O'&,#O James Allison Says Rational Combinations Key to &).*$$O%"#O7*&.,O%"&%OQO%"+(4O5#O)&(O Immunotherapy Success in "Cold" Tumors $%&.%O%"+(4+(1O&7*3%O$*'#O*/O%"#O)*0,#.O Laura Panjwani @OncEditorLaura %3'*.$O.#$-*(,+(1O+/O5#O=3$%O !""#$ Published Online: Monday, Oct 31, 2016 %&'()*+,$-+($.-!*+,$/-&*0+-1$ Immunotherapy has been a game changer in oncology, 20.3*+-&*0+$("2*%*0+% 6gO$&+,OG00+$*(6O improving survival and providing long, durable responses in melanoma, lung, head and neck cancer, and others. -.*/#$$*.O&(,O)"&+.O*/OQ''3(*0*1<O&%O The success of immunotherapies in those cancers—which TKOG(,#.$*(OC&()#.OC#(%#.:O are likely seeing a better rate of response due to their high mutational burden—is now paving the way for what are known as “cold” tumors, those that don’t have a heavy fG$O5#O3(,#.$%&(,O%"+$O7#%%#.6O5#O)&(O mutational burden or significant T-cell infiltration, said James Allison, PhD. /-&*0+-11)$#'&$&40$&5*+,%$&0,"&5"/$ “There is enough progress being made across the board that &5-&$40+6&$7'%&$('#1*2-&"$0/$2-+2"1$ I think we can start thinking about some of the colder tumors "-25$0&5"/$0'& 6O73%O 4*11$(0$(*88"/"+&$ James Allison, PhD responding if we just keep studying and making rational combination decisions,” said Allison, professor and chair of &5*+,% %"&%O)&(O&%O0#&$%O7#O&,,+%+9#6O+/O Immunology at MD Anderson Cancer Center. “As we understand this better, we can rationally put two things together that won’t just duplicate or cancel each other out, but (*%O$<(#.1+$%+):gO will do different things that can at least be additive, if not synergistic.” *()0+9#:)*'6OLFO`)%ONHF_O Ne

  21. *"%.='-"#(>-)4+34U3&#0#>D / G(O+'-*.%&(%O-&%%#.(O+(O'&(<O'#1&%.#(,$O+(O*()*0*1< / G$O+''3(*I*()*0*1<O#(%#.$O%"#Of.&%+*(&0O&$$#$$'#(%O &(,O3$#gO-"&$#O %"#.#O+$O&O(*%&70#O-3$"O/*.O)*'7+(&%+*(O*/O)*.#OQI`O,.31$O5+%"O*%"#.O )0&$$#$O*/O&1#(%O*.O*%"#.O)0&$$#$O*/O%"#.&-< / ;&(=+9 G1&.5&0& "&$O7##(O&%O%"#O/*.#/.*(%O*/O%"+$O-3$"6O.#)*''#(,+(1O %"&%O*()*0*1+$%$Of'&4#O%"#O-&%+#(%2$O%3'*.O"+$O*.O"#.O/.+#(,g / Q(%.&0#$+*(&0 %"#.&-+#$O'&<O"&9#O&..+9#,O&%O&(O*--*.%3(#O%+'# / @#O&.#O-*$+%+*(+(1OPRIFHO%*O)&-+%&0+]#O*(O%"+$O(#5O-"&$#O+(O*()*0*1<O LH

  22. C3'"#:(&'+#34'#4!A C3'"#:(&'+#34'#4!A; C3'"#:(&'+#34'#4!A KL / PRIFHO+$O&O$%#.+0#6O(*(I-<.*1#(+)O$*03%+*(O*/OA*$#OV#(1&0O,+$*,+3'O DFHnOAVEO/*.O+(=#)%+*( / AVO+$O&O #=+22'=.2&1"2&' >03*.#$)#+(O,#.+9&%+9#O&%%.+73%#,O%*Oa(#"' +(OFddN / 30$.0'<"=+%'"#&' */OAV / QRO"#-&%+)O,+&1(*$%+)6O FLF QO.&,+*0&7#0#,OAVUOOA*7#(1&%*-#o / ^#*(&%&0O3$#O/*.O"#-&%*7+00+&.< ,+&1(*$+$ / !*-+)&0O*-"%"&0'+)O,+&1(*$%+)UOOA*$#%%#$oO&(,OT+(+'$o / >**,O,<#UO>AIFH\ / ;#,+@2$#<&*'#+/&,E'<$#,.0E */OAV / ^*%O'#%&7*0+]#, / ;"*.%O)+.)30&%*.<O"&0/I0+/#OD)&OLHO'+(E / B8).#%+*(O9+&O7+0# / F,+@2&' &%O 0..=',&=)&0+,"0&' / B+*$.)+G"& / >%,0+2&#$.%+2 $%H&1,$.% )&(O<+#0,O +@2+,$8&'$=="%.,<&0+)E LF

  23. E0+3+&.04F%$%0#,/%3'4?'".'%>D / 34567'1+%'E$&2* / A&-+,O.#,3)%+*(O+(O%3'*.O73.,#( / Y+1"O.&%#O*/O*7=#)%+9#O.#$-*($# / !3'*.I$-#)+/+)O+''3(*0*1+)O&)%+9&%+*( / P*%#(%+&0O-.*0*(1&%+*(O*/OP>; / P*%#(%+&0O$<(#.1<O5+%"O*%"#.O)0&$$#$O*/O%"#.&-< / I.1.0&9$.%+2$%,&08&%,$.%'J$,<'+'#=+22'=.2&1"2&'+9&%,' +2$9%#'J$,<'1"00&%,'1+0&'#,+%*+0*#'/.0'=+%E'#.2$*',"=.0# LN

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basal cell carcinoma; NSCLC, non-small cell lung cancer LL

  25. ?%0%&'+$%4G(/#"46P0.'+#3 / -.%#$#,&%,'+@2+,$.%'$%'="2,$)2&'="0$%&'=.*&2# / T3.+(#OYCCODY#-& FI_E / T3.+(#OAGaODCCSIFZNE / T3.+(#OT#0&(*'&ODT#@*6OGLc\O&(,OVF_>FHE / T3.+(#OV.#&$%ODT!IeHFE / T3.+(#OC*0*(ODC`S`^ON_OhOC!N_E / T3.+(#OP&().#&%+)ODPG^COHNE / Y3'&(OV.#&$%ODTC>IcO&(,OY!VIFLLh!IZcKE / Y3'&(Oa&00OV0&,,#. / Y3'&(OS3(1ODY_eG.Ok $'&00O)#006O'30%+,.31O.#$+$%&(%E / Y3'&(OP.*$%&%#ODPCILE f )ABCD(%0(#'&*0.%-(.*(./4*"(.;2, g K.:OR#.(*(O;*(,&46OT*//+%%OC&()#.OC#(%#. LZ

  26. 6&&(/(0.'+#34+34E.3&%"4E%00) / 34567',0+%#$,#')2+#=+2&==+./'1+%1&0'1&22# / G))3'30&%+*(O+(O0<$*$*'#$O*/O)&()#.O)#00$ / B8)03,#,O/.*'O(*.'&0O)#00$ 30&#&%,'$%' 30&#&%,'$%'>%,&0#,$,$+2'4.2"=& >%,0+1&22"2+0'C11"="2+,$.% L.0=+2'M$##"& M"=.0 Figure 5. Composite MPE image showing a cross-section of murine tissue spanning the transition from normal skin (leftmost edge of image) to a subcutaneously implanted hepatoma tumor (area at right hand third of image). The sample was prepared by fresh frozen sectioning following systemic administration of RB. V26<@$'($@(21W+(IDJX(D'"6$$=837?((,--,Y(*.,,F()),O))Z L\

  27. 6&&(/(0.'+#34+34E.3&%"4E%00) / 34567'+11"="2+,&#'$%'2E#.#.=&#'./'1+%1&0'1&22# PRIFHO+(OY#-&FI_OYCC V26<@$' $@(21W+(IDJX(D'"6$$=837?((,--,Y(*.,-F()*EO)*C V26<@$' $@(21W+(IDJX(D'"6$$=837?((,--,Y(*.,,F()),[))Z 0">?2#8+(\<237+(]811$?;8$+(V26<@$'(23=(^$'?$B+(0$1W(R$?W((,--.Y().(4?>;1W()9F(IZ( L_

  28. 6&&(/(0.'+#34+34E.3&%"4E%00) A#,UOPRIFHOpOBKIF Y#-& FI_OC#00$ V03#UOS;a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c

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`, .HAJKN>BHA @K=1+75,I+I457@+(`1H(6(6I+( 7@E,a, 0NEF?DE%>FN@BD>%FH%NA@DE>F=A@%F?D%ODJ?=AB>O%HI% � � =JFBHA%%=A@%BF>%EHKD BA%JKBABJ=K%%O=A=RDODAF%HI% Z6193, ODK=AHO=%%=ED%M=EE=AFD@ ?%0%&'+$%4G#S+&+'D4'#4E.3&%"4E%00) &"! &!! 3B=SBKBFG%Y.HAFEHK[ %! 23456417(8 *+,##!- $! ./,"% #! � � .+53+(# "! ,*(<' 6>1@>'$ ! ! &! -! &!! "!! !&%.HAJDAFE=FBHA%Y\/Z 0">?2#8+(\<237+(]811$?;8$+(V26<@$'(23=(^$'?$B+(0$1W(R$?W((,--.Y().(4?>;1W()9F(IZ( &"! *+,##!- ./0*+10"%, &!! 3B=SBKBFG%Y%JHAFEHK%[ 1MH%OHAF?>%L'DJEH>B>%HI% %! $! BAWDJFD@%KD>BHA ,*(<' 6>1@>'$(NL(PRP( 6$11(183$? #! � � D2'=8N212($@(21W+(II:(,-)H "! ! ! '!( &) ") ') $) "#) *Z(<' 6>1@>'$ 1BOD%=IFDE%!&%=@@BFBHA 58>($@(21W+(:36"@2'7$@((,-). 239:&:,;<<+=8,6<,>?,6@,*65A)61693=71,=)7@9+(,BCD,7@E,F+11,,G3743138H,B?D,3@ *+17@6I7,=+11,13@+(,7@E,23456417(8:,J3I+,F6K5(+,6<,>?03@EK=+E,J6L3=38H,BFD / ?%0%&'+$%4'#S+&+'D4#P)%"$%:4.&"#))4/(0'+,0%4&.3&%"4&%0040+3%)4 / `2@2(6"3?8?@$3@(N8@<(?$1$6@8#$(2&12@8"3("&?$'#$=(83(%>'83$(%"=$1? Ld � � Q6@07A6A8683=,=+11,E+78) &"! CA6A86(3( &!! /DJ?=AB>O%HI%)JFBHA %.DKK%,D=F?%[ %! $! #! "! ! M9>' #BQ%/HAF?>L.KD=E=AJD HI% **"!! *+,&!!N *+1,2O .P,"% *+,##!- *+10,>* *+1,FG BAWDJFD@%KD>BHA #-//)!4 239:":,,CR,>?,B"!!,S*D,M@EK=+(,468),Q6@0CA6A8683=,7@E,CA6A8683=,F+11,T+78),3@, !H>D%&DAR=K%Y<3V6XZB>%F=UDA% bOc,C>;,?c.JCQT;>, *+17@6I7,F+11(,7<8+5,"#) ?R,216U,FH86I+85H,O3(86957I(,6<,CA6A86(3(,C((7H(,4H,8)+,VM,*+8)6E,3@ NT%SG%KG>H>HOD>%BA% *;JC.JC.;.,>;.V[QTMQZa :,.P,"%,7@E,,*+,##!-,F+11(,J5+78+E,U38),>?,B"!!,S*D,<65,"#,) /DK=AHO=%JDKK>%SNF%AHF% AHEO=K%IBSEHSK=>F>L V+5)7A(,EK+,86,MIIK@+, W0GCT -! >? 5+(A6@(+(a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`, .HAJKN>BHA @K=1+75,I+I457@+(`1H(6(6I+( 7@E,a, 0NEF?DE%>FN@BD>%FH%NA@DE>F=A@%F?D%ODJ?=AB>O%HI% � � =JFBHA%%=A@%BF>%EHKD BA%JKBABJ=K%%O=A=RDODAF%HI% Z6193, ODK=AHO=%%=ED%M=EE=AFD@ &"! &!! 3B=SBKBFG%Y.HAFEHK[ %! 23456417(8 *+,##!- $! ./,"% #! � � .+53+(# "! ! ! &! -! &!! "!! !&%.HAJDAFE=FBHA%Y\/Z &"! *+,##!- ./0*+10"%, &!! 3B=SBKBFG%Y%JHAFEHK%[ 1MH%OHAF?>%L'DJEH>B>%HI% %! $! BAWDJFD@%KD>BHA #! � � "! ! V%&"#'+&4E%004F%.'-4+34E.3&%"4E%00) ! '!( &) ") ') $) "#) 1BOD%=IFDE%!&%=@@BFBHA 239:&:,;<<+=8,6<,>?,6@,*65A)61693=71,=)7@9+(,BCD,7@E,F+11,,G3743138H,B?D,3@ *+17@6I7,=+11,13@+(,7@E,23456417(8:,J3I+,F6K5(+,6<,>?03@EK=+E,J6L3=38H,BFD � � Q6@07A6A8683=,=+11,E+78) A &"! CA6A86(3( &!! /DJ?=AB>O%HI%)JFBHA B %.DKK%,D=F?%[ %! $! #! "! J36>&2@8"3(N8@<(H-(>0 RS( M"'(*Z(<'? ! 0>'83$(0$123"%2 S). M9>' #BQ%/HAF?>L.KD=E=AJD HI% **"!! *+10,>* *+1,FG *+,&!!N *+1,2O .P,"% *+,##!- ^>%23(0$123"%2 ZZZ ^>%23(0$123"%2(4D'8%2'B9 D)+(D,+(DE ^>%23(X%&'B"386(a8=3$B ,_EU BAWDJFD@%KD>BHA 0">?$(T8&'"&12?@ EUE #-//)!4 0">?2#8+(\<237+(]811$?;8$+(V26<@$'(23=(^$'?$B+(0$1W(R$?W((,--.Y().(4?>;1W()9F(IZ( 58>($@(21W+(:36"@2'7$@((,-). 239:":,,CR,>?,B"!!,S*D,M@EK=+(,468),Q6@0CA6A8683=,7@E,CA6A8683=,F+11,T+78),3@, !H>D%&DAR=K%Y<3V6XZB>%F=UDA% bOc,C>;,?c.JCQT;>, *+17@6I7,F+11(,7<8+5,"#) ?R,216U,FH86I+85H,O3(86957I(,6<,CA6A86(3(,C((7H(,4H,8)+,VM,*+8)6E,3@ NT%SG%KG>H>HOD>%BA% *;JC.JC.;.,>;.V[QTMQZa :,.P,"%,7@E,,*+,##!-,F+11(,J5+78+E,U38),>?,B"!!,S*D,<65,"#,) / V%&"#)+)4,"%:#/+3.'%)4 +34&.3&%"4&%00)4 /DK=AHO=%JDKK>%SNF%AHF% Le AHEO=K%IBSEHSK=>F>L V+5)7A(,EK+,86,MIIK@+, W0GCT -! >? 5+(A6@(+(a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

  31. 6P0.'+$%4C//(3#'-%".,D C<4!A;KL4%0+&+')4.&('%43%&"#)+)4#@4'"%.'%:4'(/#" ! / R2;8=(3$6'"?8?("M(83b$6@$=(@>%"'?(23=('$=>6$=(@>%"'(&>'=$3 !"#$%#&' ()) *+%"#$%#&' ()) / F.D4Y4!#)';G"%.'/%3' C3:(&'+#34#@4'(/#";),%&+@+&4+//(3+'D4Z[.P)&#,.0\4 ! #"4[PD)'.3:%"\4%@@%&'] / R$7'$??8"3("M(>3@'$2@$=(@>%"'(83(8%%>3"6"%;$@$3@( 238%21? / !"($MM$6@(83(8%%>3"=$M868$3@(238%21? / R$?;"3?$(8?(@>%"'O?;$68M86 / F.D4KL4!#)';G"%.'/%3' PHCS5L.(J%%>3"6"%;$@$3@(0">?$ ZH

  32. 6P0.'+$%4C//(3#'-%".,D !"#$%"&'()*%+,-'%-.'/01,-.%"&'23$,"4/501#61'7$$3-0'8095,-90'' !"#$%&'$ !"#$AB'$ ;"/5--$ =)'3,2>5&$;0+*&$ 923&,-5'7*2,-$ ()'*'*+,-$ ()'*'*+,-$$ .03*-)1/$$ ./1<,1*2$ ?5@&5''7*2$ 92:5/1*2$ .//0+0-,1*2$ 67'&081*2$ 45--$65,3%$ B+)$*'M"=.0'C@2+,$.% FE#,&=$1'>=="%&'F,$="2+,$.% @&)"%#.O #%O&0:6O ;PQBOZ_LH6OFZc6ONHHNOD0<$*$*'&0 &))3'30&%+*(O &(,O.3-%3.#O+(O%+$$3#O)30%3.#E !"*'-$*(O#%O&0:6OT#0OA#$OFd6OZH\6ONHHdOD&70&%+*(O*/O+(=#)%#,O %3'*.$O&(,O7<$%&(,#.O .#1.#$$+*(O +(O.#)3..#(%O -&%+#(%$E !**'#<O #%O&0:6O PS*; `(#Od6O#_d\_F6ONHFLOD%3'*.I$-#)+/+)O+''3(#O .#$-*($#O +(O'+)#E S+3O#%O&0:6O GGCAONHFZOG7$%.&)%OH_LHODKCO.#).3+%'#(%h&)%+9&%+*(O &(,O!I)#00O &)%+9&%+*(O +(O'+)#E ;&.(&+4O #%O&0:6O G;C`ONHFZOG7$%.&)%OeHNdOD-CA &(,O!I)#00O&)%+9&%+*(O +(O.#/.&)%*.<O -&%+#(%$E ZF

  33. G-%4E.3&%" G-%4E.3&%"; G-%4E.3&%" C//(3+'D4ED&0% G".@@+&=+3>4 #@4G4&%00)4 '#4'(/#") / 58>($@(21W+(GGPR(,-)* / I2'328c($@(21W+(GIP:(,-)* / 58>($@(21W+(:36"@2'7$@ ,-).( !"+/+3>4 .3:4.&'+$.'+#3 / U""%$B($@(21W+(D5"I)(,-)E / 58>($@(21W+(GGPR(,-)* / I2'328c $@(21W+(GIP:(,-)* / D2'=8N212 $@(21W+(II:(,-)H / V$&$'($@(21W+(GGPR(,-). C3@+0'".'+#34 #@4G4&%00)4 +3'#4'(/#") / 58>($@(21W+(:36"@2'7$@ ,-). / 58>($@(21W+(:36"@2'7$@ ,-). / D81"3OU<"%2?($@(21W+(IJUP(,-). E.3&%"4 .3'+>%34 ,"%)%3'.'+#3 / 58>($@(21W+(GGPR(,-)* / 58>($@(21W+(IJUP(,-)H H%&#>3+'+#34 #@4&.3&%"4 &%00)4 PD4G4&%00) / 58>($@(21W+(:36"@2'7$@ ,-). / 58>($@(21W+(GGPR(,-)* / I2'328c $@(21W+(GIP:(,-)* / 58>($@(21W+(IJUP(,-)H / J("+3%4.3:4M(/.34J%0.3#/. / V$&$'($@(21W+(GGPR(,-). / 58>($@(21W+(:36"@2'7$@ ,-). / J("+3%4*"%.)' ^+00+3>4 #@4&.3&%"4 &%00) H%0%.)%4 #@4&.3&%"4 &%004 .3'+>%3) / J("+3%4EHE / U<"%;?"3($@(21W+(0$1(R$?(,--Z( / U<"%;?"3($@(21W+(0$1(R$?(,--Z( / G72'N212 $@(21W+(GIP:(,--_ / G72'N212 $@(21W+(GIP:(,--_ / J("+3%4!6VE4 / U""%$B($@(21W+(II:(,-), / U""%$B($@(21W+(D5"I)(,-)E / `$$?($@(21W+(IJUP(,-), / 58>($@(21W+(GGPR(,-)* / U""%$B($@(21W+(D5"I)(,-)E / I2'328c $@(21W+(GIP:(,-)* / V26<@$' $@(21W+(GGPR(,-)E / D2'=8N212 $@(21W+(II:(,-)H / 58>($@(21W+(GGPR(,-)* / 58>($@(21W+(IJUP(,-)H / I2'328c $@(21W+(GIP:(,-)* / V$&$'($@(21W+(GGPR(,-). / D2'=8N212 $@(21W+(II:(,-)H / 58>($@(21W+(:36"@2'7$@ ,-). / V$&$'($@(21W+(GGPR(,-). / 58>($@(21W+(:36"@2'7$@ ,-). / D81"3OU<"%2?($@(21W+(,-). `827'2%(M'"%F(P<$3(23=(0$11%23W(J%%>38@B(,-)EY(E_F()O)-W ZN

  34. K_4H%0%.)%4#@4E.3&%"4E%00463'+>%3) ^87<(0"&818@B(]'">;(S"Q()(4^0]S)9(X1$#2@$=(83(P$11(I>;$'32@23@?( `$@$6@8"3("M(^0]S)(83(@>%"'(6$11(?>;$'32@23@?( 4#82(X5JIG9(2M@$'(*Z(<'? 836>&2@8"3W(^ID_-( >36<237$=+(^IDC-(23=(J5O)2(3"@(=$@$6@$=W 58>($@(21W+(:36"@2'7$@((,-). ZL

  35. K_4H%0%.)%4#@4E.3&%"4E%00463'+>%3) ^87<(0"&818@B(]'">;(S"Q()(4^0]S)9(X1$#2@$=(83(D2@8$3@(I$'2 ^0]S)($1$#2@$=(83(?$'2("M(%$123"%2(;2@8$3@?( 2M@$'(J5(DKO)-(4!(d()*9W 58>($@(21W+(:36"@2'7$@((,-). ZZ

  36. X_4E.3&%"463'+>%34!"%)%3'.'+#3 J5(DKO)-(5$2=?(@"(`P(J3M81@'2@8"3("M(`'283837(5B%;<(!"=$? `P(4P`))6 e 0^P(JJ e 9(M'"%(@>%"'( TJUP e `P(83M81@'2@$(N<$3(TJUPO:KG(83b$6@$=( ='283837( 5!?(4`5!9( "'(3"3='283837 5!?( 83@'2@>%"'211B *(<'? 2M@$'(DKO)-(83b$6@8"3W( 4!`5!9( %$2?>'$=( &B(M1"N(6B@"%$@'BW 58>($@(21W+(GGPR(,-)* 58>($@(21W+(:36"@2'7$@((,-). Z\

  37. X_4E.3&%"463'+>%34!"%)%3'.'+#3 `P(M'"%(`5!(XQ<8&8@(J36'$2?$=(G6@8#2@8"3(02'c$'? P`*- P`Z- P`Z. * 50 PBS DSI PV-10 40 * * 30 % DCs P`))6 20 10 DKO)- 0 CD40 CD80 CD86 58>($@(21W+(:36"@2'7$@((,-). Z_

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c(0"=$1 0-H( J%0.3#/. T123c(0"=$1 PU,.( E#0#"%&'.0 T123c(0"=$1 ">'2H-!MJ!<!32&.!(*.,!1B*+C=2P*B$J!56789!,0-2,-3!"W2&!:!(*.,!,0-2,'-B,$!"1'2H-! X$ 2B3!2!+*'(=-,-!0-.(*B3-0!"1'2H-!#J!W2&!D$!20-!.)*4B!2U*F-; C p = 0.04 140 IFN-gamma levels (pg/mL) 120 n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ontrol PV-10 /-0'1201)%3*4('%5'(607. !MN-0!1B,02,C'*02=!1BO-+P*B!41,)!56789J!CB,0-2,-3! =-F-=.!1B!2!3*.-73-(-B3-B,!/2.)1*B % /-0'1201)%3*4('%5'(607. !MN-0!1B,02,C'*02=!1BO-+P*B!41,)!56789J!CB,0-2,-3! +*B,02=2,-02=! #Q#! ,C'*0.! 3-'*B.,02,-3! 2! B*B7.1HB1R+2B,! ,0-B3! ,*4203.! !"#$%&'()*+,(-. !"#$!%&'()*+&,-.!/0*'!'1+-!,0-2,-3!41,)!56789!.-+0-,-!:;<7 Figure 2. PV-10 treatment leads to tumor-specific IFN-gamma .=*4-0!,C'*0!H0*4,);!SB-!*/!.1T!2B1'2=.!-T(-01-B+-3!2!+*'(=-,-!U&.,2B3-0! 58>($@(21W+(:36"@2'7$@((,-). /*=3!'*0-!>?@A!1B!,)-!(0-.-B+-!*/!,C'*0!+*'(20-3!,*!.)2'7,0-2,-3!2B1'2=.! +*B,02=2,-02=! #Q#! ,C'*0.! 3-'*B.,02,-3! 2! B*B7.1HB1R+2B,! ,0-B3! ,*4203.! responses in mice bearing MT-901 breast cancer. Splenocytes 0-.(*B.-!1B!,)-!CB,0-2,-3!,C'*0;!! % 10 5 irradiated MT-901 tumor 10 6 , co-cultured with 2 6 !"#$%&'()*+,(-. !"#$!%&'()*+&,-.!/0*'!'1+-!,0-2,-3!41,)!56789!.-+0-,-!:;<7 were plated at 2 6 "DE!F.;!GE!(HI'%J!(!K!9;9L$!! % .=*4-0!,C'*0!H0*4,);!SB-!*/!.1T!2B1'2=.!-T(-01-B+-3!2!+*'(=-,-!U&.,2B3-0! cells, and incubated for 48 hours. Culture supernatants were analyzed D2'=8N212 $@(21W+(II:(,-)H( /*=3!'*0-!>?@A!1B!,)-!(0-.-B+-!*/!,C'*0!+*'(20-3!,*!.)2'7,0-2,-3!2B1'2=.! for IFN- c production using commercially available ELISA kit. Data shows 0-.(*B.-!1B!,)-!CB,0-2,-3!,C'*0;!! % the mean 6 SD of triplicates. *indicates p , 0.05. "DE!F.;!GE!(HI'%J!(!K!9;9L$!! % U""%$B($@(21W+(D5"I(:3$((,-)E Zc

  39. Y_4G".@@+&=+3>4#@4G4E%00)4'#4G(/#") U(P$11?(83(DS0P("M(0$123"%2(D2@8$3@? GW(P`Ze SW(P`*e PW(!aU ! ! " #$# ! ! ' , - " #$# ' , - ' , * . / 0 1 23 4# )5 1 3 6 4)78 # 220 9 ! 2: 7. / 0 1 23 4# )5 1 3 6 4)78 # 220 9 ! 2: - . / 0 12 3# )4 0 2 5 3)67 # 11/ 8 ! 19 ' , * ' , ' ' , * ' , , ' , ' ' , ' ! "# $ % &' ( ) $ * ' &* + ! "# $ % &' ( ) $ * ' &* + ! "# $ % &' ( ) $ * ' &* + 58>($@(21W+(:36"@2'7$@((,-). Zd

  40. `_4C3@+0'".'+#34#@4G4E%00)4+3'#4G(/#") J5(DKO)-(623(&""?@(U(6$11(J3M81@'2@8"3(83@"(U>%"'? S812@$'21(0-H(%$123"%2(M123c(@>%"'?(83(PHCS5L.(086$+(P`E e( 83(&B?@23=$'(@>%"'(_.(<'? 2M@$'(83b$6@8"3 58>($@(21W+(:36"@2'7$@((,-). Ze

  41. a_4H%&#>3+'+#34#@4E.3&%"4E%00) J5(DKO)-(X1868@?(T>36@8"321(U(P$11(R$?;"3?$(83(0$123"%2(D2@8$3@? G S P G>@"1"7">?( R$OI@8%>12@8"3 ` X 58>($@(21W+(:36"@2'7$@((,-). \H

  42. ! " b_4^+00+3>4#@4E.3&%"4E%00) !"%;HS G&12@8"3("M(S).(T123c(U>%"'(N8@<(IB36<'"3">?(5>37( b;KY4F.D)4!#)';HS !"%;HS b;KY4F.D)4!#)';HS ! 0$@? D2@8$3@( PV003 DK--E ! ! D2@8$3@( PV004 DK--* ! J%0.3+3464CME4 %S,"%))+#3 J3b$6@$=(U>%"' !"3OJ3b$6@$=(U>%"' 5"??("M(#82&818@B("M(83b$6@$=(23=(3"3O83b$6@$=(6>@23$">?(%$123"%2(@>%"'?( N8@<83(CO)*(=2B?("M(DKO)-(83b$6@8"3(4!(d()*(;2@8$3@?9 <+(4%'4.0_5466EH4XLKY ?."3.+=4%'4.0_546?EU4XLKY <+(4%'4.0_54 ,+-.%$"/#% XLKa \F

  43. C/,0+&.'+#3)4#@4C//(3#0#>D4F.'. / M"=.0'+@2+,$.%'1+%'&2$1$,'+'/"%1,$.%+2Q',"=.05#)&1$/$1'M'1&22'0&#).%#& / M<$#'M'1&22'0&#).%#&'$#'$=)2$1+,&*'$%' / A#1.#$$+*(O*/O3(%.#&%#,O%3'*.$ / P*%#(%+&0O-.*0*(1&%+*(O*/OP.*1.#$$+*(O>.##O;3.9+9&0ODP>;E / A&%+*(&0O,#$+1(O*/O)*'7+(&%*.+&0O$%.&%#1+#$ \N

  44. !(''+3>4G4E%00)4'#42#"= G".@@+&=+3>4 #@4G4&%00)4 '#4'(/#") / 58>($@(21W+(GGPR(,-)* / I2'328c($@(21W+(GIP:(,-)* / 58>($@(21W+(:36"@2'7$@ ,-).( !"+/+3>4 .3:4.&'+$.'+#3 / U""%$B($@(21W+(D5"I)(,-)E / 58>($@(21W+(GGPR(,-)* / I2'328c $@(21W+(GIP:(,-)* / D2'=8N212 $@(21W+(II:(,-)H / V$&$'($@(21W+(GGPR(,-). C3@+0'".'+#34 #@4G4&%00)4 +3'#4'(/#") / 58>($@(21W+(:36"@2'7$@ ,-). / 58>($@(21W+(:36"@2'7$@ ,-). / D81"3OU<"%2?($@(21W+(IJUP(,-). E.3&%"4 .3'+>%34 ,"%)%3'.'+#3 / 58>($@(21W+(GGPR(,-)* / 58>($@(21W+(IJUP(,-)H H%&#>3+'+#34 #@4&.3&%"4 &%00)4 PD4G4&%00) / 58>($@(21W+(:36"@2'7$@ ,-). / 58>($@(21W+(GGPR(,-)* / I2'328c $@(21W+(GIP:(,-)* / 58>($@(21W+(IJUP(,-)H / V$&$'($@(21W+(GGPR(,-). / 58>($@(21W+(:36"@2'7$@ ,-). ^+00+3>4 #@4&.3&%"4 &%00) H%0%.)%4 #@4&.3&%"4 &%004 .3'+>%3) / U<"%;?"3($@(21W+(0$1(R$?(,--Z( / U<"%;?"3($@(21W+(0$1(R$?(,--Z( / G72'N212 $@(21W+(GIP:(,--_ / G72'N212 $@(21W+(GIP:(,--_ R / U""%$B($@(21W+(II:(,-), / U""%$B($@(21W+(D5"I)(,-)E / `$$?($@(21W+(IJUP(,-), / 58>($@(21W+(GGPR(,-)* / U""%$B($@(21W+(D5"I)(,-)E / I2'328c $@(21W+(GIP:(,-)* / V26<@$' $@(21W+(GGPR(,-)E / D2'=8N212 $@(21W+(II:(,-)H / 58>($@(21W+(GGPR(,-)* / 58>($@(21W+(IJUP(,-)H / I2'328c $@(21W+(GIP:(,-)* / V$&$'($@(21W+(GGPR(,-). / D2'=8N212 $@(21W+(II:(,-)H / 58>($@(21W+(:36"@2'7$@ ,-). / V$&$'($@(21W+(GGPR(,-). / 58>($@(21W+(:36"@2'7$@ ,-). / D81"3OU<"%2?($@(21W+(,-). `827'2%(M'"%F(P<$3(23=(0$11%23W(J%%>38@B(,-)EY(E_F()O)-W \L

  45. ! ! V#3 V#3; V#3 E0+3+&.04E#/P+3.'+#34F.'. ! ! Combination Therapy with IL PV-10 and anti-CTLA-4 antibodies in B16-OVA bearing mice ! ! Treatment with anti-CTLA-4 antibodies in combination Treatment with anti-CTLA-4 antibodies in combination with IL with IL PV-10 results in smaller B16-OVA tumors PV-10 leads to the induction of B16-specific T cells 1600 70 Mean Tumor Weight (mg) 1400 IFN-gamma (pg/ml) 60 p=0.05 1200 50 ! ! 1000 40 800 B16 30 MC38 600 20 400 10 200 0 0 PBS PV10 anti-CTLA4 PV10+anti-CTLA4 PBS PV10 anti-CTLA4 PV10+anti-CTLA4 D81"3 U<"%2?($@(21W+( D81"3OU<"%2?($@(21W+(IJUP(,-)* \Z

  46. V#3 V#3; V#3 E0+3+&.04E#/P+3.'+#34F.'. Combination Therapy with IL PV-10 and anti-PD-1 antibodies in B16-OVA bearing mice Treatment with anti-PD-1 antibodies in combination with IL Treatment with anti-PD-1 antibodies in combination with IL PV-10 results in reduced growth of B16-OVA tumor PV-10 leads to the induction of B16-OVA-specific T cells 80 3500 p<0.05 Mean Tumor Size (mm 2 ) 70 3000 ! ! IFN-gamma (pg/ml) 60 2500 PBS 50 PV10 2000 40 anti-PD1 30 1500 PV10+anti-PD1 ! ! 20 1000 10 p<0.05 500 0 0 5 10 15 20 25 0 PBS PV10 anti-PD1 PV10+anti-PD1 Days D81"3OU<"%2?($@(21W+(IJUP(,-)* ! ! \\ ! !

  47. V#3 V#3; V#3 E0+3+&.04E#/P+3.'+#34F.'. Combination Therapy with IL PV-10 and anti-PD-L1 antibodies in B16 bearing mice Treatment with anti-PD-L1 antibodies in combination Treatment with anti-PD-L1 antibodies alone or in combination with IL PV-10 results in reduced growth of B16 tumor with PV-10 leads to the induction of B16-specific T cells 60 Mean Tumor size (mm 2 ) 2500 IFN-gamma (pg/ml) 50 2000 * * PBS + NrIgG 40 PBS + anti-PDL1 1500 30 PV10 + NrIgG 1000 PV10 + anti-PDL1 20 500 10 p<0.05 0 0 PBS PV10 anti-PDL1 PV10+anti-PDL1 0 5 10 15 20 25 *p<0.05 compared to PV-10 treated mice Days D81"3OU<"%2?($@(21W+(IJUP(,-)* IJUP(,-)* \_ ! ! ! ! ! ! ! !

  48. E#/P+3.'+#3)142-.'42%4^3#94?#48." / C**$,$8&'.0'!&,,&0'B&#).%#&'$%'S"2,$)2&'S.*&2#' / YCCO5"#(O)*'7+(#,O5+%"O\I>[OD&(%+'#%&7*0+%#E F / T#0&(*'&O5"#(O)*'7+(#,O5+%"O&(%+IC!SGIZ N / T#0&(*'&O5"#(O)*'7+(#,O5+%"O&(%+IPKIF N6L / T#0&(*'&O5"#(O)*'7+(#,O5+%"O&(%+IPKISF N / P&().#&%+)O&,#(*)&.)+(*'&O5"#(O)*'7+(#,O5+%"O1#')+%&7+(#O D(3)0#*$+,#O&(&0*1O%"&%O,#-0#%#$O'<#0*+,I,#.+9#,O$3--.#$$*.O)#00$E Z / Q(O#&)"O)&$#O%"#O)*'7+(&%+*(O&--#&.$O%*O7#O!O)#00O'#,+&%#, ) `$$?($@(21W+(IJUP(,-). , D81"3OU<"%2?($@(21W+(IJUP(,-)* E( V$&$'($@(21W+(GGPR(,-). * D81"3OU<"%2?($@(21W+(IJUP(,-). \c

  49. C/,0+&.'+#3)4@#"4E0+3+&.04F%$%0#,/%3' <#&#"%>+#3.0 J%'.)'.'+&4 I@27$(JKO0)6 !"#>"%))+#3 !"#>"%))+#3 I@27$(JKO0)& I@27$(JKO0)6 `'283837(!"=21(S2?83 P23=8=2@$?( M"'( J3OU'23?8@ E#/P+3.'+#34 HS P23=8=2@$?( M"'( ?+3>0%46>%3'4HS D'8%2'B D'8%2'B I>'#8#21F(()W,(B'? 40)&9(@"(C(%"3 40)69 I>'#8#21F((C(B'? 4JJJS9(@"()WZ(B'? 40)29 " !"+$O1#(#.&0O&--.*&)"O&--#&.$O&--0+)&70#O %*O'#0&(*'&O&(,O*%"#.O$*0+,O%3'*.$ \d

  50. J%0.3#/.4E0+3+&.04F%$%0#,/%3' / 3<+#&'6'TC"9'O77N'U C"9'O77VW / NHO$37=#)%$6O%.#&%OFINHO0#$+*($O*()#6OFILO7<$%&(,#.$O3(%.#&%#, / >*00*5O3-O%*ONZO5##4$ / P.+'&.<OBPO`AAOD'ABCQ;!E / 3<+#&'O'TX1,'O77V'U S+E'O767W / dHO$37=#)%$6O%.#&%OFINHO0#$+*($O3-O%*OZO%+'#$6O3-O%*ONO7<$%&(,#.$O3(%.#&%#, / >*00*5O3-O%*O\NO5##4$ / P.+'&.<OBPO`AAOD'ABCQ;!E / ;?)+%*&*'C11&##'TY"%'O77Z'U Y"%'O76[W / FccO'#0&(*'&O-&%+#(%$O%.#&%#, / FHO(*(I'#0&(*'&O-&%+#(%$O%.#&%#, \e

  51. J%0.3#/.4E0+3+&.04F.'. _H

  52. J%0.3#/.4E0+3+&.04F.'. !6 @##4ONZ P.#IA8 K&<OF @##4OZ ;37=#)%OHHFZUOOT&0#6O&1#OZd6O;%&1#OQQQVOD^N)EO$+()#ONHHd6O;8 */OF ` &(,O'#%$ ;+(10#O%.#&%'#(%O 5+%"OF:LO'SOPRIFHO%*OFHO0#$+*($bO FO3(%.#&%#,O 7<$%&(,#.O0#$+*(ODVFE CAO*/O!&.1#%O &(,OV<$%&(,#.OS#$+*($O&%O@##4ONZ G72'N212($@(21W+(GIP:(,-)- _F

  53. J%0.3#/.4E0+3+&.04F.'. G72'N212($@(21W+(GIP:(,-)- _N

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q ;37$%&(%+&0O%3'*.O73.,#(UOO_:LO)'O$3'O,+&'#%#.O*/O$4+(O0#$+*($OD'#,+&(E q A#/.&)%*.<O%*O&O'#,+&(O*/O_O-.#9+*3$O+(%#.9#(%+*($U A#/.&)%*.<O%*O&O'#,+&(O*/O_O-.#9+*3$O+(%#.9#(%+*($U B8)+$+*(ODFHHnO*/O-&%+#(%$E Q''3(*%"#.&-<ODNFnE ;<$%#'+)OC"#'*%"#.&-<ODFLnE ^*,&0O7+*-$<OD_LnE A&,+*%"#.&-<ODNFnE G'-3%&%+*(ODenEO A#1+*(&0O)"#'*%"#.&-<ODNZnE Q(9#$%+1&%+*(&0OG1#(%$ODFZnEO `%"#.ODdnE _L !

  55. H%),#3)%4#@4C3c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`$$a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

  56. H%),#3)%4#@4C3c%&'%:4<%)+#3) "All Treated" and "Bystanders Only" cohorts 140 121 120 1 Injection (N = 215) 2 Injections (N = 115) 100 3 Injections (N = 28) 4 Injections (N = 5) 84 (N = 363) `ad4#@40%)+#3)4.&-+%$%: `ad4#@40%)+#3)4.&-+%$%: 80 Lesions EH4.@'%"4K;X4+3c%&'+#3) G11(0$123"%2(T"11"N$=(I>&O]'">;(4!(d(H*(D2@8$3@?9 G11(0$123"%2(T"11"N$=(I>& 60 " bYd4EH49-%34.0040%)+#3)4 +3c%&'%:4 G11(0$123"%2(U'$2@$=(I>&7'">;(4!(d(,Z(;2@8$3@?(L()Z)(1$?8"3?9 40 35 25 23 22 20 13 12 11 6 5 3 2 1 0 0 0 0 0 0 0 CR PR SD PD NEV !"#$%#&#' ()'#&*+' !,-.'/012 _\

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

  58. F+)'.3'4*D)'.3:%"4H%),#3)% !"#$%&'()*+,-((./0%1(/2%(341(!'/2%(56(7.+#8(9:;&%(*))*( <=:>/=?(0%@(0AB%=(%C'=%>:'?1(>"0DE0%(!C1(0:>#(FGH1(5I5( HBA('=%/'>%;'9(7J/?()(/;K(L%%M(+,8(B:'N(<6O+)('A(3(&"'/;%A"9(0%9:A;9(:;(&/0P( ( QG(AP(:;$%&'%K(&"'/;%A"9(0%9:A;9(/'(L%%M(3*( R%;%=/0:S%K(:>E=AT%>%;'(AP(E"0>A;/=?(0%9:A;9(/'(L%%M(+*(B:'N( � ;A(PA&/0(E/=%;&N?>/0(E/'NA0A2? � (/'(L%%M(3*( !"#$%#&#' ()'#&*+' 3,4.'/01/ _c

  59. F+)'.3'4*D)'.3:%"4H%),#3)% !"#$%&'()*)+,((-./%0(.1%(2)0(!'.1%(34(5-6&7(89:&%(;))<( -"/=>/%(!?0(@ABC0(DEF/%(#G.9:(HIJ0(8'%G%F'.&=&(G.K9F8"G1%GL0(CJ3@0(34M(.:K(!NM3OB( OF"G('G%.'P%:'8(5C.L()0(Q%%R(S0(Q%%R(6;(.:K(Q%%R(6<7(D9'E(T4M6)('F(&"'.:%F"8(/%89F:8( ( TI(FU(9:$%&'%K(&"'.:%F"8(/%89F:8V((*(FU(6)(>"/PF:.GL(/%89F:8(G%8F/W%K(.'(Q%%R(6;(5TI(FU(6) 'E (:FK"/%7( !"#$%#&#' ()'#&*+' 3,4.'/01/ _d

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e

  61. C/,0+&.'+#3)4@#"4E0+3+&.04F%$%0#,/%3' <#&#"%>+#3.0 J%'.)'.'+&4 I@27$(JKO0)6 !"#>"%))+#3 !"#>"%))+#3 I@27$(JKO0)& I@27$(JKO0)6 `'283837(!"=21(S2?83 P23=8=2@$?( M"'( J3OU'23?8@ E#/P+3.'+#34 HS P23=8=2@$?( M"'( ?+3>0%46>%3'4HS D'8%2'B D'8%2'B D<2?$()&L,(D'"@"6"1( D<2?$(E(D'"@"6"1( !A;KL;JJ;KXLK !A;KL;JJ;QK I>'#8#21F(()W,(B'? 40)&9(@"(C(%"3 40)69 I>'#8#21F((C(B'? 4JJJS9(@"()WZ(B'? 40)29 cH

  62. E0+3+&.04F%$%0#,/%3'4?'".'%>D / K#$-+%#O'&=*.O&,9&()#$6O)0+(+)&0O%.+&0O.#'&+($O&O-.+'&.<O%.#&%'#(%O .#)*''#(,&%+*(O/*.O-&%+#(%$O5+%"O0*)*.#1+*(&0 ,+$#&$# !"#$%&$'()-+(,-).( cF

  63. E0+3+&.04F%$%0#,/%3'4?'".'%>D / C0+(+)&0O%.+&0O+$O&0$*O.#)*''#(,#,O/*.O-&%+#(%$O5+%"O.#)3..#(%O,+$#&$# !"#$%&$'()-+(,-).( cN

  64. E0+3+&.04F%$%0#,/%3'4?'".'%>D / !*,&<O%"#.#O&.#O&%O0#&$%OFLOQSO,.31$O+(O'#0&(*'&O)0+(+)&0O%.+&0$ F T#0&(*'&OpODQ(%.&%3'*.&0*.OQ(%.&0#$+*(&0EUO / PRIFH / Q'0<1+) / C&9&%&4 / QT`INFN\ / SSLc / ;KIFHF / Q-+0+'3'&7 / QSFe / Q^a^ONZF / Y+0%*(*0 / Ta^FcHL / !!QI_NF " Q(ONHFZO%"#.#O5#.#OZO,.31$O+(O)0+(+)&0O%.+&0$ / !*)& \FFO ) NNNWP1838621U'821?W7"#+(!"#$%&$'(),+(,-).( cL

  65. E0+3+&.04F%$%0#,/%3'4?'".'%>D / G(,O%"#.#O&.#O&%O0#&$%OcOQSO,.31$O+(O)*'7+(&%+*(O)0+(+)&0O%.+&0$ F T#0&(*'&OpODQ(%.&%3'*.&0*.OQ(%.&0#$+*(&0EOpOD-#'7.*h(+9*h+-+EUO / PRIFH / Q'0<1+) / C&9&%&4 / QT`INFN\ / ;KIFHF / Q-+0+'3'&7 / Ta^FcHL " Q(ONHFZO%"#.#O5&$OF ,.31O+(O)*'7+(&%+*(O)0+(+)&0O%.+&0$ ) NNNWP1838621U'821?W7"#+(!"#$%&$'(),+(,-).( cZ

  66. E0+3+&.04F%$%0#,/%3'4?'".'%>D / !"+$O1.*5%"O*/O%"#O$#)%*.O.#-.#$#(%$O&O,3&0I#,1#,O$5*.,U / !"#.#2$O0+%%0#O,*37%O%"&%O*3.OQSO&--.*&)"O5+%"OPRIFHO+$O$*3(, / !"#.#O+$O1.*5+(1O)*'-#%+%+*(O/*.O+(9#$%+1&%*.$O&(,O-&%+#(%$O / !"+$O+$O.#/0#)%#,O+(O*3.O,#9#0*-'#(%O&)%+9+%+#$O&(,O%+'#0+(#$ / T&8+'+]#O-&%+#(%O#0+1+7+0+%< / P3.$3#O*--*.%3(+%+#$O+(O.#1+*($O5+%"O0#$$O)*'-#%+%+*(O c\

  67. !-.)%4Q4F%)+>3 / 345675SS5P6\''30.,.1.2':$#,.0E / R#. F:FUOOH_OT&.ONHF\ / R#. F:NUOOF_O>#7ONHF_ / G,,#,OQTS?aQCO&$O)*'-&.&%*. / C0&.+/+#,O#0+1+7+0+%<O@A!O+''3(#O)"#)4-*+(%O+("+7+%*.$ / C0&.+/+#,O&(,O#8-&(,#,O#0+1+7+0+%<O@A!O%&.1#%#,O%"#.&-< / B8-&(,#,O#0+1+7+0+%<O%*O+()03,#O;%&1#OQROTF& / R#. F:LUOON\Ol3(ONHF_ / T*,+/+#,O$+]#O.#j3+.#'#(%$O/*.O!&.1#%OS#$+*($ / Q().#&$#,O%*%&0O(3'7#.O*/O0#$+*($O / R#. F:ZUOOS&%#ONHF_ / G00*5O$37)3%&(#*3$O!&.1#%OS#$+*($ / Q().#&$#O'&8+'3'O0#$+*(O$+]#O / G,,+%+*(&0O#0+1+7+0+%<O*-%+'+]&%+*( c_

  68. !-.)%4Q4TS%&('+#3 / 345675SS5P6\''30.,.1.2'B.22.", / NHF\UOG(%+)+-&%#,O&7*3%OFhLO#&)"O[;G6OG[;6OB[ / NHF_UOB8-&(,O*3%.#&)"O+(OB[O&(,O#8%#(,O%*OSG!GT6OA3$$+&6OG$+& / _HO)#(%#.$O#8-#)%#, / F_pO+(Oa#.'&(<6OQ%&0<6O>.&()#O&(,OP*0&(,O / Y&0/O+(Oa#.'&(<O5"#.#OQ'0<1+) +$O&9&+0&70# / A#130&%*.<O.#9+#5O3(,#.5&<O+(Oa#.'&(<O&(,OQ%&0< / ;%3,<O3-%&4#O#8-#)%#,O%*O7#O"+1"O+(Oa#.'&(<OD9#. F:NO&'#(,'#(%O /*)3$#,O*(O.#j3+.#'#(%$O/*.Oa#.'&(<E / ZO+(OA3$$+& / cO+(OG.1#(%+(& / \O+(OT#8+)* / \pO+(OV.&]+0 / FpO+(OC"+(& cc

  69. !-.)%4Q4TS%&('+#3 / 345675SS5P6\''30.,.1.2'B.22.", / NHF_INHFcUOB8-&(,O*3%.#&)"O%*O(#5O+(9#$%+1&%*.$O+(O[;GO&(,OG[; / B8-&(,#,O#0+1+7+0+%<O).+%#.+&O#8-#)%#,O%*O&%%.&)%O+(+%+&0O,#)0+(#$ / NHFcUO;0*5O3-%&4#O7<O[;GO&(,OG[;O+(9#$%+1&%*.$O / ;#%O%+'#0+(#$O7&)4O7<O&(O&,,+%+*(&0O_IeO'*(%"$ / ;+'30%&(#*3$O0&3()"O*/O$+%#$O+(Oa#.'&(<6O+''#,+&%#0<O/*00*5#,O7<OQ%&0<6O 5+00O$%&7+0+]#O%+'#0+(#$ / G,,+(1O'*.#O[;GO&(,OG[;O$+%#$O5+00O&0$*O$%&7+0+]#O%+'#0+(#$ / MNO*-#(+(1O*/O$+%#$O+(OSG!GT6O>.&()#6OA3$$+&O&))#0#.&%#O-.*1.#$$ / A#9+#5+(1O$#0#)%#,O*%"#.O.#1+*($O/*.O-*$$+70#O$%3,<O#8-&($+*( / ^*O/3(,&'#(%&00<O)*'-#%+%+9#O%".#&%$O#9+,#(%OD-&%+#(%O-*-30&%+*(O .#'&+($O3(,#.$#.9#,E / `9#.&00O-0&<+(1O/+#0,O+'-.*9#,O$37$%&(%+&00<ONYINHF_OD.#,3)+(1O "#&,5+(,$O1*+(1O+(%*ONHFcE cd

  70. !-.)%4Q4TS%&('+#3 / 345675SS56O76\''30.,.1.2'B.22.", / NHF\UOG(%+)+-&%#,OZI_O)#(%#.$O+(O[;G &(,OG[; / NHF_UOZO)#(%#.$O*-#(#, / NO&,,+%+*(&0O)#(%#.$O%*O*-#(OMFINHFc / C*(%#'-0&%+(1OFO/3.%"#.O)#(%#.O/*.O-"&$#OF7 / NHFcUOQ(+%+&0O-"&$#OF7O,&%&O&9&+0&70#O/*.O-.*$-#)%+9#O-&.%(#.$ / ^*O$+1(+/+)&(%O+'-&)%O*(O%+'#0+(#O/*.O+(+%+&0O$&/#%<O.#$30%$O / P.#0+'+(&.<O#//+)&)<O,&%&O(*%O#8-#)%#,O%*O7#O+'-&)%#, / G;C`OhOB;T`O+(+%+&0O-370+)O.#&,*3% / P.#-&.+(1O/*.O#8-&($+*(O*/O$%3,<O%*O-"&$#ON ce

  71. J%0.3#/.4+34'-%4O?6 9-:.3;<.=23456-34-=.36=,-./01=53=/0-=>?@ &#"### '("### ''"### %#"### '#"### $#"### 234563-4- ,-./01 &"### !#"### %"### *#"### $"### )#"### !"### (##+ (##* (##$ (##& (#'' (#'+ (#'* (#'$ 7-.8 `2@2(?">'6$F(P236$'(T26@?(f(T87>'$?(,--*(O ,-).+(G%$'8623(P 236$'(I"68$@B dH

  72. M%,.'+&4G(/#") ! !"#'#&#04!A;KL;<E;LK4Z!-.)%4K] / I8371$(83@'21$?8"321( 83b$6@8"3(83@"(6$3@$'("M(2(?8371$(?@>=B(1$?8"3 / T"11"NO>; / ,E(<">'(2=%8??8"3(M"'(838@821(?2M$@B("&?$'#2@8"3 / D'8%2'B(M"11"NO>;( 2@(,Z(=2B?(42%$3=$=( @"(2==(0"3@<(E9 / XQ@$3=$=(M"11"NO>;( M"'(.([ )H(%"3@<?(42%$3=$=( @"($#$'B(E(%"3@<?(&$7833837( 2@(0"3@<(.9 / :&?$'#$(@'$2@$=( 1$?8"3(23=(23B(>3@'$2@$=( 1$?8"3? / :>@6"%$(?6"'$=(>?837(RXPJIU(42%$3=$=( @"(,`(XGI59 / gS2?c$@(?@>=Bh(=$?873(211"N?(2??$??%$3@(83(^PP(23=(%$@2?@2@86(@>%"'? dF

  73. ?(Pc%&'4LLLK ZMEE4eK] K&<OHOk \O'+(OP*$%I!8 K&<ONdODG-.ONHFHE T*(%"OF\ODl30ONHFFE ;).##(+(1ODT&.ONHFHE K&<ONdODG-.ONHFHE T*(%"OF\ODl30ONHFFE >#'&0#6O &1#OcF6OL:ZO)'OYCCO0#$+*(O+(=#)%#,O *()#O5+%"O\:FO'SOPRIFH / dN

  74. C3+'+.04H%)(0') ! !"#'#&#04!A;KL;<E;LK4Z!-.)%4K]144C3+'+.04Kf4<%)+#3)4ZKa4!.'+%3')] / 0$=823(G7$(.Z(B$2'?(4'237$(H)([ Z_9 / ^PP([ C(1$?8"3?(4.(;2@8$3@?9(L(0$@2?@2?$?([ ))(1$?8"3?(4)-(;2@8$3@?9 F"@H&1, ]$#&+#&'+%*':$#,.0E F,+,"# 777N T6O&1#O_d YCCODY#-V &(,OC+.."*$+$E G0+9#OD^BK6O__O'*(E 7776 >6O&1#OcF YCCODNO0#$+*($O%.#&%#,O5+%"OPRIFH6OA>GE G0+9#OD5+%"OK+$#&$#6O \cO'*(6O0*$%O%*O/*00*5I3-E 777^ >6O&1#OcL YCCODY#-C6OC+.."*$+$6OP*.%&0OY<-#.%#($+*(6OA>G6O!GCBE B8-+.#,ODKP6OZdO'*(E 777_ >6O&1#O__ YCCODY#-C6OC+.."*$+$6OP*.%&0OY<-#.%#($+*(E B8-+.#,ODKP6OFNO'*(E 777V T6O&1#O_c YCC B8-+.#,ODC&.,+&)OC*'*.7+,+%<6ONO'*(E 7676 >6O&1#Ode YCCODd:eO)'E B8-+.#,OD;GB6O$3$-#)%#,O%".*'7*#'7*0+$'E 777[ T6O&1#O_F 'CAC DLO%36O>`S>`r6OG9&$%+(6OB.7+%38E G0+9#OD^BK6O\cO'*(E 7O7^ >6O&1#O_c 'CAC DA>G6O>`S>`rE G0+9#ODNFO'*(E 777Z T6O&1#Od\ 'CAC G0+9#ODF\O'*(E 7767 >6O&1#O\L 'CAC G0+9#ODKP6OLO'*(E 7O7[ >6O&1#O_c 'CACODsO_O%36O>`S>`rE B8-+.#,ODKP6OLO'*(E 7O7P T6O&1#O_e S3(1ODsOZO%36O(+9*E B8-+.#,ODKP6OFNO'*(E 7O7O T6O&1#OdL S3(1ODsO_O%36O)&.7*hG7.&8&(#E B8-+.#,ODKP6OZO'*(E 7O7N T6O&1#OdL P&().#&%+) G0+9#ODeO'*(E 767O >6O&1#O\L T#0&(*'&ODsOZO%36ONO0#$+*($O%.#&%#,O5+%"OPRIFH6O(+9*OpO+-+E B8-+.#,ODKP6OFdO'*(E 7O76 >6O&1#O\F `9&.+&(ODsOL\O%36O-&)0+%&8#0h)&.7*E B8-+.#,ODKP6OF\O'*(E dL

  75. MEE4J.3.>%/%3'4I(+:%0+3%) :-- F,+9&'7 F,+9&'CU- F,+9&'] 3FM'7Q'-<$2*U3"9<' C 3FM'7UOQ'-<$2*U3"9<' CU! 3FM'dOQ'-<$2*U3"9<' - ;%*'#,+9&'T]W 4&0E'&+02E'#,+9&'T7W ;+02E'#,+9&'TCW >%,&0=&*$+,&'#,+9&'T!W C*8+%1&*'#,+9&'T-W 6':--'`O1= 6':--'.0'P'%.*"2&# S"2,$%.*"2+0Q 3.0,+2'$%8+#$.%Q' -+01$%.=+' *+$%*&' `P1=Q'3FM'7 3FM'7 L6Q'S6Q'3FM'6UO 6':-- P'%.*"2&#'bP1= e :;B; ]X;F 34567' A>M f 3.0,+2')0&##"0&c @$2$0"@$% >%10&+#&* C##.1$+,&*'*$#&+#&# L.0=+2 L. a&# B&#&1,$.% M0+%#)2+%,+,$.% C@2+,$.% MC-; F.0+/&%$@ FE=),.=+,$1 ,0&+,=&%, -"0+,$8& ,0&+,=&%,# 3+22$+,$8&',0&+,=&%,# G,&-%#,O/.*'OV.3+8 l6O;"#.'&(OT:OY#-&%*0*1<:ONHFH:OG9&+0&70#O/.*'O"%%-Uhh555:&&$0,:*.1:O dZ S0*9#%OlT6O#%O&0:OlO^&%0OC&()#.OQ($%:ONHHdbFHHU_edIcFF:

  76. MEE4F%$%0#,/%3'4!0.3 ! 6)+.g!.&+@+&4F%$%0#,/%3'4?'".'%>+%) / D<2?$()&(L(,(:;@8"3? / D<2?$()&(IGUF(( !$"2=b>#23@ DKO)-(e(1"621(I:P(4I"'2M$38&9 / D<2?$(,(RPUF !$"2=b>#23@ DKO)-(e(1"621(I:P(#?(1"621(I:P / D<2?$()&(IGUF(( DKO)-(e(P<$6c;"83@(J3<8&8@8"3( 4D`O)(L(D`O5)9 / D<2?$(,(RPUF DKO)-(e(P<$6c;"83@(J3<8&8@8"3( #?(P<$6c;"83@(J3<8&8@8"3 / I"'2M$38& ?@>=B(@"(&$(2=#236$=(;$3=837('$?">'6$(2#2812&818@B / P<$6c;"83@(6"%&832@8"3(;$3=837(3"361838621(#218=2@8"3 / J%%>3"1"786( 6<2'26@$'8i2@8"3( 83(I8372;"'$( @"(?@2'@(j*O,-). / I>;;"'@?(6"112&"'2@8"3( N8@<(SJ(23=(;"??8&1$(0$'6c(L(S0I(L("@<$'? d\

  77. MEE4+34O?6 7+8,-329:,12+6901234+12+9,149*+,-./9319;<= '"#""" '"#""" &$#""" &$#""" &"#""" &"#""" 012341+2+ *+,-./ %$#""" %$#""" %"#""" %"#""" !$#""" !$#""" !"#""" !"#""" %""& %""$ %""( %"") %"!! %"!& %"!$ %"!( 5+,6 `2@2(?">'6$F(P236$'(T26@?(f(T87>'$?(,--*(O ,-).+(G%$'8623(P 236$'(I"68$@B d_

  78. F%$%0#,/%3'4!0.34@#"4J%'.)'.'+&4F+)%.)% ! E#3'+3(%4*.)=%'4?'(:D / :;$3(G==8@8"321(P$3@$'?(83(kIG(23=(GkI( / G11O6"%$'?(@"($Q;23=(3>%&$'?(M"'(8%;"'@23@( @>%"'(@B;$? / T"6>?$=($3'"11%$3@( "M(<87<O;'8"'8@B( @>%"'(@B;$?(4$W7W+(>#$21 %$123"%29 / !$Q@(=2@2('$;"'@837( $Q;$6@$=(T$&(,-)C(4P<8329 ! TS,0#"%4<%$%".>+3>4<E;LK4.3:4JJ;KXLK4!"#'#&#0) / P"%&832@8"3(@<$'2;B(M"'(=$%"3?@'2@$=(6"%&832@8"3? / DKO)-(e(]$%68@2&83$( M"'(;236'$2@86(2=$3"62'683"%2 / 5$#$'27$(j"5 $Q;$'8$36$(7283$=( 83(00OE) / DKO)-(e(D`O)(M"'(<$;2@86(%$@2?@2?$?("M(%$123"%2 dc

  79. U$%".004F%$%0#,/%3'4!0.3 / !+2+%1&'30$=+0E'A.1"#'J$,<':$9<'3.,&%,$+2'X)).0,"%$,$&# P.#IC0+(+)&0O S#&,$O YCCO P"&$#OF7hNOT#0&(*'& P"&$#OLOT#0&(*'& ;-#)+&0OQ(,+)&%+*($O dd

  80. ?(,,0D4E-.+3 / P.+*.+%<OK&%#UO F&),&=@&0'O767 / CQPO&(,OK+9+$+*(&0OQ$$3#, / G00*5#,O*.OQ$$3#,O+(OC&(&,&6OT#8+)*6OB[6OC"+(&6OYJ6Ol&-&(6OJ*.#&O D&5&+%+(1O`GO+(OQ(,+&E / G--0+#$OM3&0+%<I7<IK#$+1(OP.+()+-&0$O%*OT##%O a0*7&0OP3.+%<O&(,O A#-.*,3)+7+0+%<O;%&(,&.,$ de

  81. ?(,,0D4E-.+3 / !$N(?B3@<$@86(;'"6$??(?>;;123@?()ZZ-l?(]3$<% ;'"6$??( / U87<@1B(6"3@'"1?(8%;>'8@8$?(6<2'26@$'8?@86("M(<8?@"'86(;'"6$??(@"(%$$@(JP^(?@23=2'=? / R$12@$=(?>&?@236$? / I"1#$3@? / J3"'72386? / RS5(23=(DKO)-(%23>M26@>'$=(83(kIG(&B($?@2&18?<$=(='>7(%23>M26@>'$'?( / DKO)-(?;$68M862@8"3?(%$$@(T`G(23=(X0G('$m>8'$%$3@?(M"'(83b$6@2&1$(='>7 / T8'?@("M(E(!`G(?@2&818@B(1"@?(%23>M26@>'$=(^,O,-).(4Z+---(#821?(L(1"@9 eH

  82. E0+3+&.04G"+.04!"#&%)) C22'-2$%$1+2'e.0g'$#'h"$*&*'@E'>-:'30$%1$)+2#' / !"#OQ(%#.(&%+*(&0OC*3()+0O/*.OY&.'*(+$&%+*( */O!#)"(+)&0OA#j3+.#'#(%$O /*.OP"&.'&)#3%+)&0$O /*.O Y3'&(O[$#ODQCYEO7.+(1$O%*1#%"#.O%"#O.#130&%*.<O&3%"*.+%+#$O&(,O-"&.'&)#3%+)&0O +(,3$%.<O%*O $%&(,&.,+]#O$)+#(%+/+)O&(,O%#)"(+)&0O&$-#)%$O*/O,.31O.#1+$%.&%+*(:O / ;+()#O+%$O+()#-%+*(O+(OFeeH6OQCYO"&$O1.&,3&00<O#9*09#,O%*O.#$-*(,O%*O%"#O+().#&$+(10<O 10*7&0O/&)#O*/O ,.31O,#9#0*-'#(%:O / QCYX$O'+$$+*(O+$O%*O&)"+#9#O1.#&%#.O"&.'*(+$&%+*( 5*.0,5+,#O%*O#($3.#O%"&%O$&/#6O#//#)%+9#6O&(,O"+1"O j3&0+%<O'#,+)+(#$O &.#O,#9#0*-#,O&(,O.#1+$%#.#,O +(O%"#O'*$%O.#$*3.)#I#//+)+#(%O '&((#.:O " P.*9#)%3$ )*(/*.'$O%*OQCYO-.+()+-&0$O%*O&$$3.#O$&/#O&(,O#//+)+#(%O#8#)3%+*(O*/O#&)"O)0+(+)&0O $%3,<: " !"+$O+$O).+%+)&0O %*O'##%O10*7&0O.#130&%*.<O.#j3+.#'#(%$O&(,O&$$3.#O-*.%&7+0+%<O*/O$%3,<O,&%&: eF

  83. E0+3+&.04G"+.04!"#&%)) -.=)&,&%,'C",<.0$,E\'-2$%$1+2'M0$+2'C",<.0$D+,$.% -2$%$1+2'F$,& C))2$1+,$.% Q^K ;+%#OhO C!^ ^&%+*(&0O ;+%#OhO ;+%#O C!G ;AC ^&%+*(&0O ;+%#OQC> C*(%.&)% 30.,.1.2 QAVOhOBC F")).0,$%9 ;3--*.% ;3--*.% ].1"=&%,# ;3--*.% !*8 !*8 !*8 !*8 P"&.' P"&.' S*)&0 P"&.' P"&.'&)< A&,+*0*1< P"&.' PJ PJ S&7 PJ PJ CTC CTC CTC 8O L CTC QV 8O S eN

  84. E0+3+&.04G"+.04!"#&%)) -2$%$1+2'F$,& ;+%#OP&%+#(%OP*-30&%+*( ;+%#O C*(%.&)% Q(9#$%+1&%+*(&0O !#&' P*%#(%+&0O;37=#)%$ 30.,.1.2 ;+%#OQC> B0+1+70#O;37=#)%$ eL

  85. E0+3+&.04G"+.04!"#&%)) -2$%$1+2'F$,& A&5O;%3,<OK&%& Q(9#$%+1&%+*(&0O ;%3,<O !#&' ;37=#)% ;-*($*. S*)&0OhO Q'&1#O P"*%*I QTP CA>$OhO T*(+%*. PA`OhO C#(%.&0O C*.#O ,*)3'#(%I &(,O #CA>$ #PA` S&7$ S&7 &%+*( 30.,.1.2 ;3--0<O S*1+$%+)$ C#(%.&0O;%3,<OK&%&7&$# eZ

  86. E0+3+&.04G"+.04!"#&%)) >%*&)&%*&%,'B&8$&J'-.==$,,&&'T>B-W'+%*';%*).$%,'C##&##=&%,'-.==$,,&&'T;C-W Q'&1#O P"*%*I CA>$OhO C*.#O ,*)3'#(%I #CA>$ &%+*( S&7 ;%3,<O ;37=#)% A&, K#.' QAC QAC B(,-*+(%OG$$#$$'#(%OC*''+%%##ODBGCE `//+)+&0OBP e\

  87. E0+3+&.04G"+.04!"#&%)) ]+,+'C%+2E#$# `//+)+&0OBP ;%3,<O 8O L `//+)+&0OBP ;37=#)% ;%&%+$%+)&0O ;%3,< G(&0<$+$O `//+)+&0OBP B//+)&)<O BPD$E D-#.O;GPE `//+)+&0OBP `//+)+&0OBP e_

  88. E0+3+&.04G"+.04!"#&%)) F+/&,E'C%+2E#&# S*)&0OhO CA>$OhO C#(%.&0O #CA>$ S&7$ ;%3,<O 8O L ;37=#)% ;%3,<O ;%&%+$%+)&0OG(&0<$+$OD-#.O;GPE ;&/#%<O BPD$E ec

  89. E0+3+&.04G"+.04!"#&%)) F,"*E'B&).0,$%9 ;%3,<O ;&/#%<O BPD$E ;%3,<O B//+)&)< C;A BPD$E ;%3,<O !&70#$O&(,O ;%3,<OPRIFHIPJIHF S+$%+(1$ / dO$37=#)%O-"&.'&)*4+(#%+)O $%3,< / ddZO-&1#$ ed

  90. E0+3+&.04G"+.04!"#&%)) F,"*E'S+%+9&=&%,'U (FC'+%*'C(F F,"*E'F$,&# C*.#O A#130&%*.<O / C*(%.&)%+(1 K*$$+#. / S*)&0OG--.*9&0 / ;ACOhOOQAVOQ(%#./&)# / ;%3,<OT*(+%*.+(1 / C**.,+(&%+(1O5+%"O;%3,<OR#(,*.$O P.*%*)*0 DC#(%.&0OS&76OP"*%*1.&-"<6O#%)E / C**.,+(&%#O;%3,<O;3--0+#$ Q(9#$%+1&%*.O V.*)"3.# ee

  91. E0+3+&.04G"+.04!"#&%)) F,"*E'S+%+9&=&%,'U ;"0.)&Q'ICMCSQ'C#$+ -BX F,"*E'F$,&# C*.#O S*)&0O A#130&%*.<O A#130&%*.<O / C*(%.&)%+(1 K*$$+#. K*$$+#. / S*)&0OG--.*9&0 / ;ACOhOOQAVOQ(%#./&)# / ;%3,<OT*(+%*.+(1 / C**.,+(&%+(1O5+%"O;%3,<OR#(,*.$O P.*%*)*0 P.*%*)*0 DC#(%.&0OS&76OP"*%*1.&-"<6O#%)E / C**.,+(&%#O;%3,<O;3--0+#$ D!.&($0&%#,E Q(9#$%+1&%*.O QV " ;-*($*.O.#%&+($O30%+'&%#O.#$-*($+7+0+%<O/*.O V.*)"3.# D!.&($0&%#,E $&/#O&(,O#//+)+#(%O#8#)3%+*(O*/O$%3,< FH H

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend